Susan L. McElroy, MD
- 89Articles
- 346.1KReads
- 1997–2020Active
- 237Collaborators
- 6KCitations
About
Susan L. McElroy, MD, has published extensively on psychiatric disorders including bipolar disorder, eating disorders, weight-related issues, major depressive disorder, schizophrenia and schizoaffective disorders, obsessive-compulsive and related disorders, sexual dysfunction, and mood disorders. Her work encompasses clinical trials and studies on treatments such as dasotraline and lisdexamfetamine for binge-eating disorder, genetic risk factors in early-onset bipolar disorder, and comparative effectiveness of pharmacologic interventions for bipolar disorder. She has contributed to research on diagnostic criteria modifications, illness burden across generations, and comorbidities like tobacco dependence and obesity in severe mental illness. Her publications span from 1997 to 2020 in peer-reviewed journals affiliated with Psychiatrist.com.
Publications
Amphetamine Withdrawal After Lisdexamfetamine Cessation
March 26, 2020
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
